Non-valvular Atrial Fibrillation
4 competing products in clinical development for Non-valvular Atrial Fibrillation.
Pipeline by Phase
Pre-clinical2
Phase 31
Approved1
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| DU-176b 15mg + DU-176b 30mg + DU-176b 60mg | Daiichi Sankyo | Phase 3 | Completed | 40 |
| Edoxaban + Aspirin and Clopidogrel + Aspirin and Warfarin | Daiichi Sankyo | Approved | UNKNOWN | 39 |
| Edoxaban | Daiichi Sankyo | Pre-clinical | Completed | 26 |
| Edoxaban | Daiichi Sankyo | Pre-clinical | Completed | 26 |